OPS
VRNA

Orion Portfolio Solutions’s Verona Pharma VRNA Stock Holding History

Orion Portfolio Solutions’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$249K Buy
+3,918
New +$234K ﹤0.01% 1711
2024
Q4 		– Sell
-12,051
Closed -$347K – 1918
2024
Q3 		$347K Sell
12,051
-1,898
-14% -$46.7K ﹤0.01% 1472
2024
Q2 		$202K Sell
13,949
-805
-5% -$11.8K ﹤0.01% 1643
2024
Q1 		$237K Sell
14,754
-2,085
-12% -$36.1K ﹤0.01% 1552
2023
Q4 		$341K Sell
16,839
-1,477
-8% -$21.8K ﹤0.01% 1360
2023
Q3 		$299K Sell
18,316
-900
-5% -$17.3K ﹤0.01% 1381
2023
Q2 		$406K Buy
19,216
+1,125
+6% +$24K ﹤0.01% 1292
2023
Q1 		$363K Buy
+18,091
New +$391K ﹤0.01% 1273

Other funds holding VRNA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return